Ultra-high-throughput PCR testing system for SARS-CoV-2 detection
Complete 5,000 test results per hour on a proven molecular genomics testing platform with unmatched capacity
It’s time to redefine large-scale COVID-19 testing. For labs to prepare for the next surge with scalable capacity, LGC Biosearch Technologies offers an ultra-high-throughput (uHTP) end-point PCR testing system for SARS-CoV-2 detection now granted Emergency Use Authorization (EUA).
The Biosearch Technologies workflow combines the Nexar™ industrial scale, automated end-point PCR testing platform with our robust, high-quality testing reagent components. UgenTec’s FastFinder software seamlessly integrates with Biosearch Technologies’ instrumentation to provide full traceability of the sample down to individual wells on the Array Tape™ consumable, which allows the user to easily pull up a sample’s status.
See if ultra-high-throughput is right for your lab
Sample
collection
Sample receipt
and preparation
Lysis and
inactivation
Amplification
and detection
Data interpretation
and workflow
management
Why choose Biosearch Technologies' SARS-CoV-2 testing system?
- Now granted Emergency Use Authorization by the US FDA.
- Achieve unparalleled capacity by completing 5,000 test results per hour on a single platform (over 100,000 test results per day).
- Validated for screening symptomatic and asymptomatic individuals.
- Compatible with anterior nares specimens self-collected at home or by a healthcare professional.
- Easy dry swab collection device that’s safe for handling, better for shipping, and automation-friendly once received by the laboratory.
- Extraction-free process streamlines handling without compromising gold-standard PCR sensitivity of a 250 cp/swab limit of detection (LoD).
The LGC, Biosearch Technologies SARS-CoV-2 ultra-high-throughput End-Point RT-PCR Test
Biosearch Technologies’ SARS-CoV-2 testing workflow can expand testing capacity at 5,000 completed test results per hour with minimal need for additional staff, instrumentation, or lab space. This optimised package of hardware, reagents, consumables and software includes:
The industrial scale Nexar™ (end-point PCR) and Hydrocycler2™ (thermal cycling) platforms.
UgenTec’s AI-powered workflow automation, PCR analysis and reporting software.
A dedicated customer service representative who ensures that your supply, hardware and service needs are anticipated and met.
Technical documents
Title
Type
Download
- EUA210561 LGC Biosearch Technologies FDA Letter of Authorization
IFU
- Biosearch Technologies SARS-CoV-2 ultra-high-throughput End-Point RT-PCR Test
IFU
- Biosearch Technologies SARS-CoV-2 ultra-high-throughput End-Point RT-PCR Test
FACT SHEET FOR PATIENTS
- Biosearch Technologies SARS-CoV-2 ultra-high-throughput End-Point RT-PCR Test
FACT SHEET FOR HEALTHCARE PROVIDERS
- Biosearch Technologies SARS-CoV-2 ultra-high-throughput End-Point RT-PCR Test
Product Information Card
- UgenTec SARS-CoV-2 CE-IVD Interpretive Software Instrument and Software Information
Protocol
